Neogen Chemicals · risk themes across the available quarters.
Bear-case history
Key US customer has delayed plant audit scheduling due to ongoing tariff and policy uncertainty. Management is selling limited volumes to non-regulated markets (China) as interim measure while awaiting approvals.
US tariff policy remains fluid with potential exemptions for battery materials. Management acknowledged difficulty predicting outcomes but noted Japan/Korea/India compete differently than China-based suppliers.
Dahej bromine capacity expansion to 2,500 MT will require ~15-day shutdown in Q2 FY26 to connect to existing facilities. Timing could affect agro segment recovery and international customer supplies.
Analyst questioned loss on profit estimate from fire incident; management deflected stating process only begins post-plant reinstatement, making FY26 impact uncertain. Net receivable of INR 268.27 crore is outstanding with INR 80.55 crore received.
Electrolyte revenues are dependent on domestic ACC PLI gigafactory ramp-ups. Four of six planned gigafactories are expected to start by FY27, but delays in stabilization could impact ₹100 crore electrolyte guidance.
Despite ₹582 crore cumulative EBITDA over five years, operating cash flow has been negative at ₹93 crore due to high working capital intensity (140-160 days). Management targets improvement by FY28-29 but no specific commitment.
Analyst raised concern about liquid electrolyte's limited shelf life affecting export logistics. Management clarified electrolytes are for local market only; exports limited to stable components (salts, additives, solvents).
Some Indian cell manufacturers with Chinese technology partners may face pressure to use Chinese formulations initially. Management is working with 5 of 6 gigafactories but faces 3-6 month qualification period before customer switching.
Multiple customers have postponed on-site audits to March/April/May, pushing final approvals beyond initial Q1 timelines. Some customers may wait for Patanjali's larger capacity instead of Dahej.
Inventory DSO and receivables increased due to toll manufacturing transition and inventory build-up ahead of Dahej restart. Target of 140-160 days inventory by FY27 year-end may pressure cash flows.
Excluding Neoen Ionics, inorganic chemical revenue trend is downward, solely attributed to lithium price decline. Management expects Q4/Q1 benefit from recent lithium price spike.
$20M (~$170 crore) equity from Morita is delayed pending bank approval for asset separation into subsidiary. Expected by Q1 FY27 but dependent on regulatory processes.